Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Omega Therapeutics's share price for the quarter that ended in Sep. 2024 was $1.22. Omega Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 55.16 Mil. Therefore, Omega Therapeutics's market cap for the quarter that ended in Sep. 2024 was $67.29 Mil.
Omega Therapeutics's quarterly market cap
declined
from Mar. 2024 ($201.32 Mil) to Jun. 2024 ($114.17 Mil) and
declined
from Jun. 2024 ($114.17 Mil) to Sep. 2024 ($67.29 Mil).
Omega Therapeutics's annual market cap
declined
from Dec. 2021 ($541.49 Mil) to Dec. 2022 ($274.50 Mil) and
declined
from Dec. 2022 ($274.50 Mil) to Dec. 2023 ($165.99 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Omega Therapeutics's Enterprise Value for Today is $97.92 Mil.
Omega Therapeutics (OTCPK:OMGAQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Omega Therapeutics Market Cap Related Terms
Omega Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Omega Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Omega Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Therapeutics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Omega Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Omega Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Omega Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Therapeutics (OMGAQ) has a Market Cap of $0.17 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Omega Therapeutics and its competitors.
Is Omega Therapeutics' Market Cap too high?
Omega Therapeutics' current Market Cap is $0.17 Mil. The Biotechnology industry median Market Cap is 114.03. Omega Therapeutics' value of $0.17 Mil is 99.9% below this industry median. Overall, Omega Therapeutics has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Omega Therapeutics' Market Cap compare to ENDV and ORGS?
Omega Therapeutics' Market Cap of $0.17 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 114.03. Omega Therapeutics' value of $0.17 Mil is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.03, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Therapeutics's current Market Cap of $0.17 Mil is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Omega Therapeutics and its competitors. For the Biotechnology industry, the median Market Cap is 114.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Therapeutics's current Market Cap is $0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Therapeutics stock overvalued right now?
Omega Therapeutics (OMGAQ) has a current Market Cap of $0.17 Mil. The current Market Cap is $0.17 Mil and 99.9% below the Biotechnology industry median of 114.03. Omega Therapeutics' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Omega Therapeutics (OMGAQ), the current Market Cap is $0.17 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
16GF Score
Get the complete analysis for OMGAQ
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OMGAQ has been successfully added to your 
